SCHEMBL4050404

SCHEMBL4050404

COc1ccccc1C1CC1C(=O)Nc1sc2c(c1C#N)CCN(C(=O)O)C2

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.51
KMT2A Q03164 6/20 0.51
ALDH1A1 P00352 3/20 0.51
MAPT P10636 3/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
KDM4E B2RXH2 1/20 0.50
GRM1 Q13255 6/20 0.47
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
GRM5 P41594 1/20 0.45
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
STAT3 P40763 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4773237 0.91 MEN1 (0.49) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4766247 0.90 MEN1 (0.48) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL2894811 0.90 ALDH1A1 (0.47) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4775113 0.90 MAPK10 (0.48) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4776547 0.89 ALDH1A1 (0.49) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4775582 0.86 MEN1 (0.50) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL13239798 0.86 MEN1 (0.46) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL13265463 0.85 MAPK10 (0.46) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL2890873 0.85 STAT3 (0.47) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4769342 0.85 MEN1 (0.45) MEN1KMT2AALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051983-A1 NTETRAHYDROPYRIDOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF CANCER 4SC AG (DE) 2009-04-29 EP disclosed
WO-2008020024-A1 NTETRAHYDROPYRIDOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF CANCER 4SC AG (DE) 2008-02-21 WO disclosed